Ben Sasse Enrolls in Pancreatic Cancer Clinical Trial After Diagnosis

The enrollment of former senator Ben Sasse into a promising pancreatic cancer trial highlights the ongoing search for effective treatments in a disease with limited options. The recent trial results showing nearly doubled survival could influence future treatment standards and patient choices. Watching how Sasse’s participation impacts perceptions of clinical trials in aggressive cancers will be key.